Maravai LifeSciences Inc.
MRVI | NASDAQ
$7.17
+$0.20 (+2.87%)
At close: Sep 21, 2026, 4:00 PM ET
$7.30
+$0.13 (+1.81%)
After-hours:
Sep 21, 2026, 7:30 PM ET
Market Data
Market Cap $1.93B
Enterprise Value $1.94B
Beta 0.61
Average Volume 3.31M
Shares Outstanding (Diluted) 147.22M
Shares Change YoY 2.07%
Institutional Ownership 82.93%
Exchange NASDAQ
ISIN US56600D1072
Price Performance
Price Change 1M -15.7%
Price Change 3M 33.5%
Price Change 6M 130.6%
Price Change YTD 110.9%
Price Change 1Y 160.7%
Price Change 3Y -25.3%
Price Change 5Y -85.5%
1M CAGR (ann.) 11.5%
1Y CAGR (ann.) 148.0%
5Y CAGR (ann.) -31.8%
All-Time CAGR -22.1%
Valuation
PE Ratio -13.28
Forward PE N/A
PEG Ratio -0.14
Forward PEG 0.80
PS Ratio 9.49
Forward PS 8.80
PB Ratio 9.68
P/FCF Ratio -56.41
P/Adj. FCF Ratio -32.41
P/OCF Ratio -42.18
EV/Sales 9.30
EV/EBIT -20.32
EV/EBITDA -28.94
EV/FCF -55.29
Earnings Yield -7.5%
FCF Yield -1.8%
Adj. FCF Yield -3.1%
Financial Health
Net Cash $39.38M
Total Debt $30.72M
Cash & Short-Term Investments $70.09M
Total Assets $603.75M
Current Ratio 4.05
Quick Ratio 2.98
Debt / Equity Ratio 0.86
Debt / EBITDA -0.46
Debt / FCF -0.87
OCF / Debt -0.82
Interest Coverage 4.01
Altman Z-Score 4.70
Piotroski F-Score 5
Margins & Profitability
Gross Profit Margin 34.6%
Operating Profit Margin 46.0%
EBITDA Margin -27.4%
Net Profit Margin -37.1%
FCF Margin -16.8%
Adj. FCF Margin -29.3%
SBC / Revenue 12.5%
SBC Impact (per share) -74.1%
Returns
Return on Assets -12.8%
Return on Equity -35.4%
Return on Invested Capital 16.9%
Return on Capital Employed 17.0%
Return on Tangible Assets -23.0%
Historical Growth (CAGR)
Revenue CAGR 3Y -27.3%
Revenue CAGR 5Y -17.7%
Revenue CAGR 10Y N/A
EPS CAGR 3Y 23.8%
EPS CAGR 5Y -291.1%
EPS CAGR 10Y N/A
FCF CAGR 3Y -28.2%
FCF CAGR 5Y -103.1%
FCF CAGR 10Y N/A
Analyst Forecasts
Analyst Rating Buy
Analyst Count 14
EPS Growth Next 3Y 24.7%
Revenue Growth Next 3Y 6.6%
Earnings Date N/A
EPS Estimate (next Q) N/A
EPS Growth Est (next Q) N/A
Revenue Est (next Q) N/A
Revenue Growth Est (next Q) N/A
Fair Value Estimates
Graham Number N/A
Graham Upside N/A
Lynch Fair Value N/A
Lynch Upside N/A
Price Target $7
Price Target Upside -2.4%
Cash Flow
Operating Cash Flow $-25.26M
Free Cash Flow $-35.11M
Adj. Free Cash Flow $-61.11M
FCF Per Share -$0.24
OCF Per Share -$0.17
OCF/S Ratio -12.1%
Income Statement
Revenue $208.78M
Gross Profit $72.25M
Operating Income $96.09M
EBITDA $-67.07M
Net Income $-77.39M
EPS (Diluted) -$0.54
Revenue / Employee $503.07K
Profit / Employee $-186.47K
Employees 415
Add to Watchlist
Select watchlists to add or remove MRVI